![Mark A. Varney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark A. Varney
Fondateur chez
Neurolixis, Inc.
Profil
Mark A. Varney is the founder of Neurolixis, Inc. Prior to founding Neurolixis, he held several positions in the pharmaceutical industry, including President, CEO & Director at RespireRx Pharmaceuticals, Inc., Director-San Diego Facility at Merck & Co., Inc., Director-Neuropharmacology at Sibia Neurosciences, Inc., Vice President & Head-Discovery at Sumitomo Pharma America, Inc., and Vice President-Drug Discovery at Bionomics Ltd. Varney holds a doctorate from the University of Oxford and an undergraduate degree from the University of Surrey.
Postes actifs de Mark A. Varney
| Sociétés | Poste | Début |
|---|---|---|
Neurolixis, Inc.
 Neurolixis, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops novel treatments for disorders of the central nervous system | Fondateur | - |
Anciens postes connus de Mark A. Varney
| Sociétés | Poste | Fin |
|---|---|---|
| RESPIRERX PHARMACEUTICALS INC. | President | 22/03/2013 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Corporate Officer/Principal | 01/01/2006 |
Bionomics Ltd.
 Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Corporate Officer/Principal | 01/06/2004 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/04/2003 |
Sibia Neurosciences, Inc.
 Sibia Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule therapeutics for disorders of the nervous system | Corporate Officer/Principal | 01/09/1999 |
Formation de Mark A. Varney
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
RespireRx Pharmaceuticals, Inc.
 RespireRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that discovers and develops drug therapies for the treatment of sleep apnea, respiratory depression & other brain-mediated breathing disorders | Health Technology |
Sibia Neurosciences, Inc.
Sibia Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule therapeutics for disorders of the nervous system | Health Technology |
Neurolixis, Inc.
Neurolixis, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops novel treatments for disorders of the central nervous system | Commercial Services |
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Surrey
 University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
